Disclosures for "Eye Movement and Lid Disorders in Patients With Alternating Hemiplegia of Childhood due to ATP1A3 Gene Variants"
-
Dr. Al-Abdulghani has nothing to disclose.
-
Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mendelics Genomic Analysis. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving as a Consultant for EBSCO publishing. Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Outcome Solutions. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeuthics. The institution of Dr. DeGusmao has received research support from FDA.
-
Dr. Brodsky has nothing to disclose.
-
Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for florida legal. Dr. Zee has received publishing royalties from a publication relating to health care. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lectuer with u of pittsburg physical therapy. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lecturer with johms hopkins CME.
-
Author has nothing to disclose
-
Mr. Castro has nothing to disclose.
-
Dr. Mochida has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Mochida has received research support from National Institutes of Health. The institution of Dr. Mochida has received research support from Rare Village Foundation.
-
Dr. Rucker has nothing to disclose.